-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

2023 ASH Guideline Implementation Champions

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI)
Sunday, December 10, 2023: 9:30 AM-11:00 AM
Room 7 (San Diego Convention Center)
Rachel P. Rosovsky, MD, Massachusetts General Hospital and Amy L Billett, MD, Dana-Farber Cancer Institute, Inc.
Rosovsky: Penumbra: Consultancy, Other: National Lead Investigator for STORM PE; Janssen: Consultancy, Other: Research funding is to my institution, Research Funding; Abbott: Consultancy; Dova: Consultancy; BMS: Consultancy; Pulmonary Embolism Response Team: Membership on an entity's Board of Directors or advisory committees, Other: President-Elect; Inari: Consultancy.
This session, led by Drs. Rachel Rosovsky and Amy Billett, recognizes practitioners who have been working to implement recommendations for evidence-based guidelines at the point of care in their clinical settings. Each year, a few individuals are selected from a pool of applicants to present their strategies for successful implementation.